Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Rosalind Rei


Latest From Rosalind Rei

Gloomy First Half Results For Mayne

Revenue falls 33% over the half year for the ailing Australian pharmaceutical as it pivots from generics to the branded market

Sales & Earnings Generic Drugs

Chemiphar Profit Slumps 82.5% In Q3

Plummeting sales and profit following government price regulations pushes Chemiphar to target international expansion

Japan Sales & Earnings

Teva To Hand Florida $6.73m Over Price-Fixing Allegations

Teva has agreed to settle Florida’s price-fixing allegations for $6.73m, its fifth and largest state settlement sum so far. Payouts to further states are expected.

United States Legal Issues

FDA Begins Reviewing Henlius’ Trastuzumab

The US FDA has accepted a BLA for Henlius’ trastuzumab biosimilar candidate HLX02, marking another step in the Chinese company’s push for the US oncology market

Oncology Regulation

Torrent’s Brazil Growth Surges 36% In Q3

Torrent’s quarterly revenues were up by 18% to INR24.9bn in Q3 FY2023. Branded generics and the Brazilian market did much of the heavy lifting.

India Sales & Earnings

New Insulin Manufacturer For Civica

Ypsomed AG will manufacture insulin dosing injector pens for non-profit Civica. Civica has also paired up with AmerisourceBergen for generics supply chain support across the US.

Deals Manufacturing
See All